Skip to Main Content

Just hours before one of its executives is set to testify at a Congressional hearing to review insulin pricing, Sanofi (SNY) on Wednesday offered a program that will lower the cost of the diabetes treatment to $99 a month for uninsured patients and others who pay cash in the U.S.

Under the plan, the drug maker maintained patients can buy up to 10 boxes of insulin pens or vials with a valid prescription, beginning in June, and expands a program that began a year ago in which patients were paying $99 for each vial of insulin and $149 for each pack of insulin pens.


“The value is for the individual who does not have insurance and is subject to high list prices,” said Michelle Carnahan, who heads the North America Primary Care unit at Sanofi. “If they’re below the poverty level, we have patient assistance programs, but if not, there’s nothing” for them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Any individual can purchase a generic brand of insulin at Walmart pharmacy for less than $25.00 per vial. A prescription is not even required. I discovered this when my mother had no Rx coverage. It seems few people are aware of this.

Comments are closed.